LP-X in cholestasis.

Area of Science:

• Hepatology
• Biochemistry

Background:

• Biliary obstruction, both intrahepatic and extrahepatic, presents diagnostic challenges.
• Lipoprotein X (Lp-X) is an abnormal lipoprotein associated with cholestasis.

Purpose of the Study:

• To investigate the presence and diagnostic utility of Lipoprotein X (Lp-X) in patients with biliary obstruction of various etiologies.
• To determine if Lp-X can aid in differentiating between intrahepatic and extrahepatic biliary obstruction.

Main Methods:

• Studied 62 patients with extrahepatic and intrahepatic biliary obstruction.
• Investigated the presence of Lipoprotein X (Lp-X) in patient serum samples.
• Correlated Lp-X presence with specific diagnoses and timing of obstruction relief.

Main Results:

• Lipoprotein X (Lp-X) was detected in a high percentage of patients with cholestasis due to gallstones (19/20), primary biliary cirrhosis (3/3), and benign recurrent intrahepatic cholestasis (3/3).
• Lp-X was also found in patients with cirrhosis (2/4), hepatitis (5/13), recurrent jaundice of pregnancy (1/2), and Dubin-Johnson syndrome.
• Lp-X levels decreased or disappeared after relief of obstruction, and its appearance time varied with etiology.

Conclusions:

• Lipoprotein X (Lp-X) is a sensitive marker for biliary obstruction but does not reliably differentiate between intrahepatic and extrahepatic causes.
• The timing of Lp-X appearance may offer some diagnostic clues in specific cases.
• Caution is advised regarding surgical intervention in cholestatic patients without detectable Lp-X.